🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study of comparative pharmacokinetics and biosimilarity of drugs containing...
Status
Completed
Location
Yarosslavl Clinical Hospital #3
Start Date
2023-06-30
Trial ID
NCT06497049
This study is a multicenter, randomized, open, parallel-controlled, Phase I...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-01
Trial ID
NCT07046273
The study is testing the incidence of MACE and incidence of renal events be...
Status
Enrolling By Invitation
Location
NIS- Tianjin Medical University Chu Hsien-I Memorial Hospital-Department of Endocrinology
Start Date
2026-02-13
Trial ID
NCT07456774
The goal of this clinical trial is to learn if Empagliflozin and Semaglutid...
Status
Recruiting
Location
Research Institute of the McGill University Health Centre
Start Date
2025-04
Trial ID
NCT06894784
Obesity is a widespread and preventable condition affecting over a billion ...
Status
Completed
Location
IRCCS Catholic University of Rome
Start Date
2022-05-01
Trial ID
NCT06820047
Treatments Being Tested
This study is a randomized, open-label, single-dose, parallel-controlled bi...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2024-09-22
Trial ID
NCT06634927
The aim of this study is to evaluate whether exposure to semaglutide influe...
Status
Completed
Location
University of Southern Denmark
Start Date
2021-01-26
Trial ID
NCT04572165
Treatments Being Tested
The goal of this clinical trial is to evaluate the similarities in efficacy...
Status
Unknown
Location
Multiple Locations
Start Date
2024-04
Trial ID
NCT06339086
Treatments Being Tested
This is a randomized, single-blind, controlled, parallel clinical trial to ...
Status
Recruiting
Location
KGK Science Inc.
Start Date
2026-02-05
Trial ID
NCT07195994
Treatments Being Tested